X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8004) 8004
Book Review (1883) 1883
Publication (539) 539
Newsletter (190) 190
Newspaper Article (81) 81
Magazine Article (52) 52
Book Chapter (42) 42
Conference Proceeding (21) 21
Trade Publication Article (12) 12
Book / eBook (11) 11
Dissertation (9) 9
Reference (2) 2
Transcript (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6464) 6464
humans (5865) 5865
proton pump inhibitors (4574) 4574
male (3376) 3376
female (2971) 2971
middle aged (2300) 2300
gastroenterology & hepatology (2151) 2151
adult (1981) 1981
omeprazole (1840) 1840
pharmacology & pharmacy (1811) 1811
aged (1766) 1766
proton pump inhibitors - therapeutic use (1509) 1509
proton pump inhibitors - administration & dosage (1427) 1427
treatment outcome (1399) 1399
proton pump inhibitor (1238) 1238
lansoprazole (1057) 1057
animals (1055) 1055
risk factors (1051) 1051
helicobacter infections - drug therapy (1000) 1000
gastroesophageal reflux - drug therapy (985) 985
drug therapy, combination (975) 975
helicobacter pylori (971) 971
proton pump inhibitors - adverse effects (947) 947
gastroesophageal reflux (880) 880
abridged index medicus (814) 814
therapy (803) 803
medicine & public health (776) 776
dosage and administration (771) 771
anti-ulcer agents - administration & dosage (727) 727
care and treatment (723) 723
omeprazole - administration & dosage (718) 718
anti-ulcer agents - therapeutic use (708) 708
2-pyridinylmethylsulfinylbenzimidazoles (700) 700
drug therapy (686) 686
aged, 80 and over (664) 664
drug administration schedule (650) 650
omeprazole - analogs & derivatives (633) 633
research (633) 633
drug interactions (630) 630
medicine, general & internal (629) 629
risk (594) 594
health aspects (584) 584
time factors (569) 569
gastroesophageal-reflux disease (560) 560
rabeprazole (559) 559
pharmacokinetics (557) 557
double-blind (550) 550
dose-response relationship, drug (540) 540
hydrogen-ion concentration (538) 538
prospective studies (535) 535
omeprazole - therapeutic use (532) 532
adolescent (530) 530
pantoprazole (527) 527
proton-pump inhibitors (513) 513
internal medicine (512) 512
retrospective studies (511) 511
management (489) 489
young adult (487) 487
gastroenterology (484) 484
infection (458) 458
rats (453) 453
anti-bacterial agents - administration & dosage (452) 452
analysis (450) 450
esomeprazole (447) 447
anti-bacterial agents - therapeutic use (444) 444
disease (441) 441
helicobacter pylori - drug effects (440) 440
proton pump inhibitors - pharmacology (430) 430
administration, oral (428) 428
complications and side effects (425) 425
gastroesophageal reflux disease (415) 415
oncology (410) 410
metaanalysis (392) 392
omeprazole - pharmacology (384) 384
clopidogrel (381) 381
double-blind method (370) 370
drugs (366) 366
amoxicillin - administration & dosage (365) 365
diagnosis (359) 359
protons (359) 359
endoscopy (356) 356
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (353) 353
prevention (350) 350
nonsteroidal antiinflammatory drugs (349) 349
ulcers (345) 345
histamine h2 antagonists - therapeutic use (344) 344
surgery (342) 342
aspirin (341) 341
efficacy (336) 336
ticlopidine - analogs & derivatives (328) 328
eradication (326) 326
helicobacter-pylori infection (325) 325
pharmacology/toxicology (325) 325
clarithromycin - administration & dosage (323) 323
follow-up studies (320) 320
prevalence (320) 320
anti-inflammatory agents, non-steroidal - adverse effects (317) 317
triple therapy (313) 313
peptic ulcer (310) 310
gastroenterology and hepatology (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7791) 7791
German (119) 119
Japanese (116) 116
Russian (88) 88
Spanish (75) 75
French (63) 63
Korean (57) 57
Italian (12) 12
Chinese (11) 11
Hungarian (8) 8
Danish (7) 7
Polish (7) 7
Norwegian (6) 6
Czech (5) 5
Dutch (5) 5
Swedish (5) 5
Ukrainian (4) 4
Portuguese (2) 2
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2010, Volume 56, Issue 2, pp. 134 - 143
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 45, pp. 17127 - 17131
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 6, pp. 809 - 815.e1
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 28 - 35
Journal Article
Canadian Medical Association Journal, ISSN 0008-4409, 03/2009, Volume 180, Issue 7, pp. 713 - 718
Journal Article
AURIS NASUS LARYNX, ISSN 0385-8146, 02/2017, Volume 44, Issue 1, pp. 122 - 125
Presently, the relationship between laryngopharyngeal reflux (LPR) and radiation-induced mucositis has not been fully explored. In the present study, we report... 
Laryngopharyngeal reflux | HEAD | Mucositis | OTORHINOLARYNGOLOGY | Radiation | Head and neck cancer | RADIOTHERAPY | NECK-CANCER | Proton pump inhibitor
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 8, pp. 872 - 879
Objectives This study sought to determine whether known genetic, drug, dietary, compliance, and lifestyle factors affecting clopidogrel absorption and... 
Cardiovascular | Internal Medicine | pharmacokinetics | risk factors | receptors | drugs | platelets | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | GENOTYPE | REACTIVITY | TRIAL | CIGARETTE-SMOKING | PARAOXONASE-1 | RESISTANCE | PRASUGREL | ABSORPTION | ASSOCIATION | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Drug Monitoring - methods | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation - genetics | Cardiovascular Diseases - etiology | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | Platelet Function Tests - methods | Aryldialkylphosphatase - genetics | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Cross-Over Studies | Smoking - metabolism | Confounding Factors (Epidemiology) | Proton Pump Inhibitors - pharmacokinetics | Blood Coagulation - drug effects | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Cardiovascular Diseases - psychology | Patient Compliance | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Phosphates | Drugs | Prescribing | Medical colleges | Continuing medical education | Metabolites | Vasodilators | Cytochrome P-450 | Physiological aspects | Proton pump inhibitors | Genetic aspects | Patient compliance | Research institutes | Studies | Cytochrome | Body mass index | Nutrition research | Genotype & phenotype | Demographics | Drug therapy | Acute coronary syndromes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article